Our Strategic Alliances
Genetis thrives through the collaboration of esteemed partners:
Australian biotech company dedicated to the research and clinical development of innovative vaccines.
French-Thai biotech firm developing innovative vaccine recombinant technology and developer of world’s only monovalent recombinant acellular pertussis vaccine.
Victorian CMO specializing in biopharmaceutical manufacturing for clinical trials.
Together, we deliver integrated solutions for mRNA, DNA, and recombinant protein vaccines and therapeutics.